Background Prescription medication is the primary approach to COPD management, alongside lifestyle changes.

Aim To assess patient views on treatment preference and adherence to optimise COPD management.

Methods Qualitative patient and provider insight data were collected from three sources in 2021: interactions between HCPs and GSK; social media sites (specialist and non-specialist); and an independent online patient survey. A content analysis method was used to anonymise, collate and categorise data using key words to identify common themes.

Results HCP interactions constituted 2966 entries and provided HCP-reported patient insights. Social media data included 988 posts (a subset of which [n=153] included 97% patients, aged 41?<81 years). Forty-four survey respondents included 33 patients (mild-moderate COPD) and 11 caregivers aged 20?69 years. Based on insights from HCP/GSK interactions and social media, patients lacked disease and treatment option understanding, highlighting the need for improved patient education (Table). For treatment preference, patients reported one dose (triple therapy) is more convenient than several different inhaled therapies, and may increase likelihood of greater adherence (Table).

Conclusions This analysis revealed common themes around patient treatment preference and adherence including suboptimal disease understanding and device/dosage education.

Funding GSK-sponsored study